EQO, INC.

Agritech · Private

Engineered biopesticide combining enzymatic toxin domains with antibody-derived targeting fragments to selectively control zebra and quagga mussel infestations

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Agritech
Total capital
$225K
Federal grants
$225K
1 award · 2019
Rank in peer group#12 of 36
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2023
Rank in peer group#4 of 36

Capital timeline

2019FEDERAL ↑EQUITY ↓Cumulative $225K$225K
2019FEDERAL ↑EQUITY ↓Cumulative $225K$225K

Latest events

  • Federal grantNSF · Phase I · SBIR Phase I: Investigation of a Bioengineered Immunotoxin for Use as a Biopesticide for the Control of Aquatic Invasive Mussel Infestation$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 36 peers

Line = median

Agritech · Molecule

  • Federal grants#12 · top 33%
  • Granted patents#4 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 2

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .